title: Chelated metal ions for therapeutic and diagnostic applications.
abstract: Use of radiolabeled monoclonal antibodies (mAb's) that localize and bind to malignant cells continues to be an attractive mechanism for targeting and delivering either an imagable isotope, be it a y-emitter or B(+)-emitter, or a particle emitter such as a B(-)-emitter or an a-emitter for therapeutic applications.
authors.affiliation: Radioimmune & Inorganic Chemistry Section, DCS, NCI, NIH, Bethesda, MD 20892, USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Brechbiel
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001729:Bismuth; D002614:Chelating Agents; D006801:Humans; D007553:Isotope Labeling; D007554:Isotopes; D008670:Metals; D009369:Neoplasms / Q000175:diagnosis / Q000628:therapy; D004369:Pentetic Acid
chemical_list: D000911:Antibodies, Monoclonal; D002614:Chelating Agents; D007554:Isotopes; D008670:Metals; D004369:Pentetic Acid; D001729:Bismuth